News for 'genomics'

COVID-19: How to Prevent Third Wave

COVID-19: How to Prevent Third Wave

Rediff.com24 May 2021

'It is important for all of us to understand to have 1. COVID-19-appropriate behaviour, even after vaccination and 2. to try to increase the vaccination drive.'

When you engineer a virus, you leave behind...'

When you engineer a virus, you leave behind...'

Rediff.com29 Jun 2021

'...signatures.' 'But such signatures are missing in this virus.'

Coronavirus hits children less severely than adults, says study

Coronavirus hits children less severely than adults, says study

Rediff.com14 Mar 2020

'However, the importance of children in transmitting the virus remains uncertain,' the scientists cautioned in the study. 'Coronaviruses are a large family of viruses that can cause infection and disease in animals, capable of rapid mutation and recombination, leading to novel viruses that can spread from animals to humans,' they said.

30 groups in India trying to develop COVID-19 vaccine: PSA

30 groups in India trying to develop COVID-19 vaccine: PSA

Rediff.com28 May 2020

Without naming the entity, he said some players are at a pre-clinical stage and may reach the clinical stage by October. Responding to a question on absence of a vaccine currently and the prospects in the next few months as the lockdown eases, VijayRaghvan emphasised on aggressive rapid testing and tracking.

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'

4 detected with SA Covid variant, 1 with Brazil strain: Govt

4 detected with SA Covid variant, 1 with Brazil strain: Govt

Rediff.com16 Feb 2021

All travellers and contacts have been tested and quarantined.

Is Xi likely to be overthrown?

Is Xi likely to be overthrown?

Rediff.com10 Jun 2021

China's presence in the international dog house is just the kind of opportunity that his opponents must be waiting for, predicts Colonel Anil A Athale (retd).

Detecting cancer

Detecting cancer

Rediff.com12 Jan 2019

It isn't one disease. It can attack different organs and there are very significant differences in the treatment modes for each.

Maha: New curbs in Pune; 7-day lockdown in Amravati

Maha: New curbs in Pune; 7-day lockdown in Amravati

Rediff.com21 Feb 2021

The central probe agency had on Friday carried out a fresh round of searches in connection with the case, they said.

'One must be cautious, not scared, of the new variants'

'One must be cautious, not scared, of the new variants'

Rediff.com31 Mar 2021

'SARS-CoV-2 is going to change to avoid/overcome any thing thrown at it.'

Xi offers help to Trump to combat COVID-19

Xi offers help to Trump to combat COVID-19

Rediff.com27 Mar 2020

Trump spoke to Xi over telephone, days after the US president angered Beijing by referring to the coronavirus as "Chinese virus" and his Secretary of State Mike Pompeo said China's ruling Communist Party poses a substantial threat" to Americans' health and their way of life.

Air pollution may hinder India's fight against COVID-19: Scientists

Air pollution may hinder India's fight against COVID-19: Scientists

Rediff.com27 Oct 2020

Long-term exposure to chronically high PM2.5 levels weakens the ability of the lungs to fend off infections, therefore making people more susceptible to COVID-19, the scientists said.

Everyone above 45 yrs to be vaccinated from April 1

Everyone above 45 yrs to be vaccinated from April 1

Rediff.com23 Mar 2021

The countrywide vaccination drive was rolled out on January 16 with healthcare workers getting inoculated and vaccination of the frontline workers started from February 2.

Indian city among world's leading hubs for start-ups

Indian city among world's leading hubs for start-ups

Rediff.com26 Nov 2012

Let's take a look world's leading cities for start-ups, including one from India.

'Vaccinations are not a 100% guarantee'

'Vaccinations are not a 100% guarantee'

Rediff.com14 Jul 2021

'The reality of this virus is that as long as it is circulating, it can mutate into new variants and by the time you realise that this is a new virus, which is more dangerous, and more transmissible, it is too late.'

Bharat Biotech starts Covaxin's at-risk manufacture

Bharat Biotech starts Covaxin's at-risk manufacture

Rediff.com2 Nov 2020

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.

Coronavirus may have mutated, potentially evolving: Study

Coronavirus may have mutated, potentially evolving: Study

Rediff.com24 Sep 2020

'Wearing masks, washing our hands, all those things are barriers to transmissibility, or contagion, but as the virus becomes more contagious it statistically is better at getting around those barriers'

Who will get COVID-19 vaccine first? Vardhan explains

Who will get COVID-19 vaccine first? Vardhan explains

Rediff.com11 Oct 2020

'The prioritisation of groups for COVID-19 vaccine shall be based on two key considerations -- occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality'

Blame game at this juncture is suicidal

Blame game at this juncture is suicidal

Rediff.com12 May 2021

To build one's political and ideological arguments on the dead bodies piling up outside our crematoriums is despicable and breaches the basic tenet of human civility, argues Vivek Gumaste.

Meet the Indian who won Europe's biggest scholarship

Meet the Indian who won Europe's biggest scholarship

Rediff.com5 Jun 2012

Alok Arun, who is currently working on his PhD at the Station Biologique de Roscoff in France after winning the Erasmus Mundus -- Europe's biggest scholarship -- is also the only Indian to be part of a global genome project that he says will influence the life cycle of an organism.

Beijing COVID-19 situation 'extremely severe': Official

Beijing COVID-19 situation 'extremely severe': Official

Rediff.com16 Jun 2020

The authorities have mounted massive containment measures including mass testing of about 90,000 people

Thapar among 12 asked to submit CVs: JNU admin

Thapar among 12 asked to submit CVs: JNU admin

Rediff.com2 Sep 2019

The JNU administration's decision to ask historian Thapar to submit her CV for assessment for her continuation as professor emerita drew sharp criticism from various quarters.

Is 'localised' herd immunity behind dip in India's Covid count?

Is 'localised' herd immunity behind dip in India's Covid count?

Rediff.com5 Jan 2021

While there is a glimmer of hope and India's COVID-19 numbers are on a definite decline for a combination of reasons, a vaccination programme continues to be important, particularly given the presence of a mutant, more transmissible strain, several experts said while cautioning against infection upticks ahead.

Covishield: 'Single dose gives 71% effectiveness'

Covishield: 'Single dose gives 71% effectiveness'

Rediff.com20 Jul 2021

'You have sufficient protection if you take the second dose of the Covishield vaccine at 12 weeks, because this vaccine works in a way where it provides protection in the first dose.'

Controversial study that claimed HCQ unsafe for COVID-19 retracted

Controversial study that claimed HCQ unsafe for COVID-19 retracted

Rediff.com5 Jun 2020

'Several concerns were raised with respect to the veracity of the data and analyses conducted by Surgisphere Corporation and its founder'

Geneticist Raj Barathur passes into the ages

Geneticist Raj Barathur passes into the ages

Rediff.com27 Aug 2020

Raj Barathur -- Indian American entrepreneur, geneticist, professor and biopharmaceutical industry leader -- stayed the course even when diagnosed with lung cancer

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

Beijing becomes 'no-go-zone' as COVID-19 cases jump to 106

Beijing becomes 'no-go-zone' as COVID-19 cases jump to 106

Rediff.com16 Jun 2020

The Chinese capital reported 106 domestically transmitted COVID-19 cases since June 11 and a senior city official warned that the situation is "extremely severe" in Beijing where authorities have mounted massive containment measures including mass testing of about 90,000 people.

China exonerates itself in whitepaper on COVID-19

China exonerates itself in whitepaper on COVID-19

Rediff.com7 Jun 2020

A whitepaper released by the Chinese government gave a lengthy explanation to refute the allegations of cover up and delay by Beijing on reporting the COVID-19 outbreak last year in Wuhan. United States President Donald Trump and leaders of several countries have accused China of not being transparent in reporting the deadly disease, leading to huge human casualties and economic crisis across the world.

COVID-19 tip of the iceberg, says China's 'Bat woman'

COVID-19 tip of the iceberg, says China's 'Bat woman'

Rediff.com26 May 2020

Shi explained that she and a group of researchers obtained samples of coronavirus on December 30 last year and performed high-throughput sequencing of the samples and the isolation of pathogens.

British-Indian professor knighted in New Year's honours

British-Indian professor knighted in New Year's honours

Rediff.com31 Dec 2016

Balasubramanian, 50, Herchel Smith Professor of Medicinal Chemistry at Cambridge University, has been recognised for his work as a co-inventor of Next Generation DNA sequencing, described as the most transformational advance in biology and medicine for decades.

North India could see 100,000 cases per state per day

North India could see 100,000 cases per state per day

Rediff.com19 Apr 2021

'The trajectory of the disease will keep increasing because of the population density being very high.'

Maharashtra opts for a facelift

Maharashtra opts for a facelift

Rediff.com4 Mar 2010

To this end, the state has roped in Ernst & Young (E&Y) to prepare a master plan. E&Y outbid KPMG to win the Rs 1.65 crore (Rs 16.5-million) contract from Maharashtra Industrial Development Corporation.

COVID-19 here to stay till 2021: Health experts

COVID-19 here to stay till 2021: Health experts

Rediff.com27 May 2020

Coronavirus is a '12-18 months' problem and the world is not going to be free of this till 2021, says Professor Ashish Jha.

Want to know how long you will live? Read this

Want to know how long you will live? Read this

Rediff.com2 Jul 2010

A mix of around 150 variations in DNA sequence could act as an effective predictor of whether a person has the genetic artillery to live up to 100 years, researchers have found.

'Emergence of another coronavirus is inevitable'

'Emergence of another coronavirus is inevitable'

Rediff.com13 May 2020

'The worst case scenario is a rebound of the virus.' 'Life is not going to be what it was.' 'Life as we know it has changed forever.' 'The new normal therefore is test, trace and treat.'

Junior research fellowship in Biophysics Sciences

Junior research fellowship in Biophysics Sciences

Rediff.com20 Apr 2007

Saha Institute of Nuclear Physics, Kolkata invites applications for MSc/Junior Research Fellowship programme in Biophysical Sciences.

Gene that causes Anaemia 'discovered'

Gene that causes Anaemia 'discovered'

Rediff.com13 Oct 2009

An international team, led by the Queensland Institute of Medical Research, has identified the new variant of a gene, TMPRSS6, by analysing the genome of 4,800 healthy individuals from Australia and the Netherlands.

Indian biotech firms on the move

Indian biotech firms on the move

Rediff.com30 Jul 2008

Companies are offering services in drug discovery and validation based on pathway analysis (that is, analysis of how toxic or radioactive substances reach humans), genomics (study of gene sequences in living organisms), proteomics (large-scale study of proteins) and translational research (clinical investigation with human patients or volunteers).

'Severity, deaths not higher, but more transmissible'

'Severity, deaths not higher, but more transmissible'

Rediff.com2 Apr 2021

'People are just putting the mask below their nose.' 'They are only protecting the mouth, but not the nose.' 'People need to understand that it is the nose which has to be protected.'